Health Policy Podcast copertina

Health Policy Podcast

Health Policy Podcast

Di: Atlas Point Media
Ascolta gratuitamente

The Health Policy Podcast explores how healthcare policy decisions impact patients, providers, costs, and innovation across the U.S. healthcare system. Through interviews with physicians, policy experts, researchers, and industry leaders, the podcast examines the real-world effects of laws, regulations, and market forces shaping healthcare today.2026 Politica e governo Scienze politiche
Episodi
  • Patient's Rising's Terry Wilcos: The gap between FDA approval and patient access for Alzheimer's treatments

    Patient's Rising's Terry Wilcos: The gap between FDA approval and patient access for Alzheimer's treatments
    Jul 16 2026

    Terry Wilcox, Co-founder and CEO of Patients Rising, discusses the critical gap between FDA approval and patient access for new early-onset Alzheimer's treatments. She shares personal insights from her experience as a caregiver and explains how the ASAP Act aims to fix the policy hurdles preventing families from accessing life-changing innovation.
    Mostra di più Mostra meno
    19 min
  • American Commitment's Phil Kerpen: The Hidden Drivers of Hospital Consolidation

    American Commitment's Phil Kerpen: The Hidden Drivers of Hospital Consolidation
    Jul 14 2026

    Phil Kerpen, President of American Commitment, joins the show to discuss why hospitals often escape public blame for rising healthcare costs despite vertical price increases. He explains how tax-exempt status, "facility fees," and the consolidation of independent physician groups have eroded competition. The conversation also explores the massive lobbying power of health systems and how federal regulations like the medical loss ratio inadvertently incentivize higher spending.
    Mostra di più Mostra meno
    21 min
  • Dr. Jeremy Levin: Why Biotech Is Not Big Pharma

    Dr. Jeremy Levin: Why Biotech Is Not Big Pharma
    Jul 7 2026

    Dr. Jeremy Levin, author of 'Biotech in the Balance,' explains why small biotech firms—not Big Pharma—are the true engines of medical discovery. He discusses the sector's unique capital risks and the growing public distrust that threatens the future of American innovation.
    Mostra di più Mostra meno
    24 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione